“Pricing is the moment of truth,” but developing a pricing strategy for optimal market access is difficult
This is because the mix of payers who determine market access hurdles changes with the country and the setting of care. Understanding value pricing in pharma’s multi-stakeholder and international environment is therefore critical for pricing executives, and for all functions interacting with key stakeholders in the market access process.
This course will teach you the techniques and approaches that have been proven to work best for value pricing in pharma.
Learn what’s vital in pharma pricing:
- Who are the payers?
- How are different country pricing systems structured?
- What are the best pricing research techniques?
- What are the essential components of an effective pricing strategy?
What our clients think
I have already recommended it as a good introduction to pricing. It really demonstrated how price is a consequence of many factors. Everything was concisely presented & engaging with a good level of participation within the group. This course is useful for someone new to pricing but also comes with practical tips for the more experienced.
Visit CEL for more information
By clicking this button, you will be leaving our web site. Inpharmation is not responsible for the content of the destination site. You will be subject to the destination site’s privacy policy and terms and conditions when you follow the link.
Pricing & Access Strategies
Want to learn more about pricing & market access research that expects the unexpected during drug development?
